M. Terasawa

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
M Terasawa, M. Terasawa, Michio Terasawa
Publication record
70 papers · 311 citations · H-index 10

PAPERS

Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells.
20005 citationsauthor #6
Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
19976 citationsauthor #6
Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs
199723 citationsauthor #7
Suppressive effects of Y-24180, a long-acting antagonist for platelet-activating factor, on allergic pulmonary eosinophilia in mice.
199711 citationsauthor #4
Effects of Y-24180, a long-acting and potent antagonist to platelet-activating factor, on immediate asthmatic response in guinea pigs.
199716 citationsauthor #6
Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
19965 citationsauthor #4
Structural optimization of 4-(2-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-[1,2,4]triazolo[4,3-a][1,4]diazepines as antagonists for platelet activating factor: pharmacological contribution of substituents at the 2- and 6-positions of a condensed ring system
19967 citationsauthor #7
[Mechanism of analgesic action of Y-23023, a new non-steroidal anti-inflammatory drug].
19950 citationsauthor #7
[Analgesic and anti-inflammatory effect of (+/-)-N,N- dimethylcarbamoylmethyl 2-[7-(2-methyl-5H-[1] benzopyrano [2,3-b] pyridyl)] propionate (Y-23023), a new non-steroidal anti-inflammatory drug].
19950 citationsauthor #6
Effect of Y-20811, a long-lasting TXA2 synthetase inhibitor, on LPS-induced airway hyperreactivity in guinea-pigs.
19930 citationsauthor #4
[Advance in eosinophil chemotaxis assay method--automatic count of migrated cells by the image analyzing system in the Boyden method].
19930 citationsauthor #4
Medicament for the treatment of autoimmune diseases
19920 citationsauthor #7
Drugs for the treatment of autoimmune diseases
19920 citationsauthor #7
Enhancement of host defense by Y-25510, (+-)-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4 -b] pyridine-1-acetic acid, a novel synthetic compound. A comparison with recombinant human granulocyte colony-stimulating factor in 5-fluorouracil-treated mice.
19922 citationsauthor #3
Suppression of the Arthus reaction by Y-24180, a potent and specific antagonist of platelet-activating factor
19926 citationsauthor #3
Effect of a potent PAF antagonist, Y-24180, on an allergen-induced late asthmatic response in guinea-pigs.
19928 citationsauthor #6
Effect of Y-20811, a long-lasting thromboxane A2 synthetase inhibitor, on antigen-induced airway hyperresponsiveness in guinea pigs.
19913 citationsauthor #4
[Effects of Y-20811, a specific thromboxane A2 synthetase inhibitor, on chemical mediator-induced bronchoconstriction in guinea pigs].
19911 citationsauthor #5
[Platelet-activating factor (PAF) antagonists].
19910 citationsauthor #1
Effect of cysteine ethylester hydrochloride (Cystanin) on host defense mechanisms (V): Potentiation of nitroblue tetrazolium reduction and chemiluminescence in macrophages or leukocytes of mice or rats.
19904 citationsauthor #3
Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.
199040 citationsauthor #4
Pharmacological actions of Y-24180: I. A potent and specific antagonist of platelet-activating factor.
199040 citationsauthor #1
Effect of Y-20811, a potent and new thromboxane A2 synthetase inhibitor, on experimental asthma in guinea pigs and rats
19901 citationsauthor #2
Stimulation of phagocytic activity of leukocytes and macrophages by traxanox sodium in mice and rats.
19893 citationsauthor #2
[Synthesis, pharmacological activity and biopharmaceutical characteristics of alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetates].
19891 citationsauthor #5
Thienotriazoldiazepinverbindungen and their pharmaceutical applications
19890 citationsauthor #3
Effect of cysteine ethylester hydrochloride (Cystanin) on host defense mechanism (IV): Potentiating effects on the function of peritoneal or spleen macrophages.
19884 citationsauthor #4
Increased serum immunoreactive prolyl hydroxylase in rats with carrageenan-induced granuloma and adjuvant arthritis.
19881 citationsauthor #4
Benzopyranopyridinessigsäureester compounds and their pharmaceutical applications.
19880 citationsauthor #3
[Anti-rheumatic action of cysteine ethylester hydrochloride].
19880 citationsauthor #4
Effect of etizolam (Depas) on production of superoxide anion by platelet-activating factor and N-formyl-methionyl-leucyl-phenylalanine-stimulated guinea pig polymorphonuclear leukocytes.
19886 citationsauthor #3
[Effects of traxanox sodium on experimental nasal allergy].
19880 citationsauthor #1
Correlationships between pain threshold and met-enkephalin-like peptide levels in adrenal medulla and plasma of adjuvant-induced arthritic rats.
19871 citationsauthor #4
[Mechanism of the inhibitory effect of pranoprofen on sodium urate crystal-induced inflammation].
19871 citationsauthor #5
PAF antagonistic activity of some thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines.
19879 citationsauthor #3
An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding.
198713 citationsauthor #5
Antagonistic activity of etizolam on platelet-activating factor in vivo experiments.
198713 citationsauthor #1
[Effect of pranoprofen on sodium urate crystal-induced inflammation].
19871 citationsauthor #1
An antagonistic activity of etizolam (Depas®) on platelet-activating factor (PAF). II. Effect on PAF-induced hypotension, bronchocon-striction and isolated ileum contraction
19862 citationsauthor #1
Influence of Y-20003, an analgesic agent, on the endogenous opioid peptide system in rats.
19861 citationsauthor #4
[Analgesic effect of topically applied pranoprofen-gel].
19852 citationsauthor #1
[Anti-inflammatory effect of topically applied pranoprofen-gel].
19851 citationsauthor #1
[Effect of traxanox sodium on inflammatory response].
19850 citationsauthor #1
[Effect of traxanox on antibody formation in BALB/c mice].
19841 citationsauthor #3
Effect of traxanox on immune response in BALB/c mice
19840 citationsauthor #2
Effect of pranoprofen-gel on acute inflammation
19840 citationsauthor #3
Effect of pranoprofen-gel on chronic inflammation
19840 citationsauthor #3
Studies on the Synthesis and Antiallergic Activity of 5H-[1]-Benzopyrano[2,3-b]pyridine Derivatives.
19830 citationsauthor #3
Traxanox augments immune response to lipopolysaccharide in inbred mice: role of macrophages.
19832 citationsauthor #3
[Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].
19834 citationsauthor #1
[Studies on the synthesis and antiallergic activity of 5H-[1]-benzopyrano[2,3-b]pyridine derivatives].
19833 citationsauthor #4
Influence of a new anti-allergic agent, traxanox sodium, on arachidonate cascade
19822 citationsauthor #1
Immunopotentiating action of traxanox on immune response to lipopolysaccharide
19820 citationsauthor #2
Abstract of the second international conference on immunopharmacolgyTraxanox augments suppressor T cell induction: Role of macrophages
19822 citationsauthor #3
Inhibitory effect of traxanox sodium on IgE-mediated histamine release from passively-sensitized mast cells of the rat in vitro.
198213 citationsauthor #3
Contents, Vol. 68, 1982
19820 citationsauthor #62
[[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
19822 citationsauthor #1
[Effect of Y-12, 141 on immune response of dd mice. Studies on anti-allergic agents, V. (author's transl)].
19812 citationsauthor #3
Effect of a new analgesic agent, miroprofen, on carrageenin-induced rat pleulsy
19810 citationsauthor #1
[Effect of predosing with Y-12,141 on its antiallergic activity. --Studies on anti-allergic agents(IV)-- (author's transl)].
19811 citationsauthor #2
Anti-inflammatory activity of an imidazopyridine derivative (miroprofen).
198111 citationsauthor #3
Influence of a new anti-inflammatory agent, pranoprofen, on gastro-intestinal organ in mice
19812 citationsauthor #2
Effects of Y-12, 141 in allergic reactions type I, III and IV in vivo
19801 citationsauthor #2
IMMUNOPHARMACOLOGICAL PROPERTIES OF NEW ANTIALLERGIC AGENT Y-12,141
19800 citationsauthor #2
Anti-anaphylactic activities of a new benzopyranopyridine derivative Y-12,141 in rats and guinea pigs.
19808 citationsauthor #2
Anti-allergic activities of a new benzopyranopyridine derivative Y-12,141 in rats.
197918 citationsauthor #2
[Anti-allergic activity of 7-acetyl-5-oxo-5H-[1] benzopyrano (2,3-b] pyridine (Y-9000) (author's transl)].
19781 citationsauthor #2
[Inhibitory effect of 2-(5H-[1]benzopyrano[2,3-b]pyridin-7-yl)propionic acid (pranoprofen) on platelet aggregation (author's transl)].
19771 citationsauthor #3
[Pharmacological studies of 2-(5H-(1)benzopyrano(2,3-b)pyridin-7-yl)propionic acid (Y-8004). (I) Anti-inflammatory, analgesic and antipyretic actions].
19750 citationsauthor #2
Proceedings: Anti-inflammatory activity of 2-(5H-(1)benzopyrano(2,3-b) pyridin-7-yl) propionic acid (Y-8004).
19740 citationsauthor #3

TIMELINE

1974 0 citations

1975 0 citations

1977 1 citations

1978 1 citations

1979 18 citations

1980 9 citations

1981 16 citations

1982 19 citations

1983 9 citations

1984 1 citations

1985 3 citations

1986 3 citations

1987 38 citations

1988 11 citations

1989 4 citations

1990 85 citations

1991 4 citations

1992 16 citations

1993 0 citations

1995 0 citations

1996 12 citations

1997 56 citations

2000 5 citations

COAUTHOR MAP

CONCEPT FOOTPRINT